Home Finance Moderna Confirms FDA Delayed Covid-19 Vaccine in Adolescents to Review Myocarditis Risk

Moderna Confirms FDA Delayed Covid-19 Vaccine in Adolescents to Review Myocarditis Risk

33
0

Moderna Confirms FDA Delayed Covid-19 Vaccine in Adolescents to Evaluation Myocarditis Risk


< img srcset=" https://images.wsj.net/im-426597?width=540&size=1.5 540w, https://images.wsj.net/im-426597?width=620&size=1.5 620w, https://images.wsj.net/im-426597?width=639&size=1.5 639w, https://images.wsj.net/im-426597?width=860&size=1.5 860w, https://images.wsj.net/im-426597?width=860&size=1.5&pixel_ratio=1.5 1290w, https://images.wsj.net/im-426597?width=860&size=1.5&pixel_ratio=2 1720w, https://images.wsj.net/im-426597?width=860&size=1.5&pixel_ratio=3 2580w" src= "https://images.wsj.net/im-426597?width=860&height=573" design=" responsive "placeholder height=" 573" width =" 860" alt > Moderna stated more than 1.5 million adolescents have actually gotten its vaccine. A 16-year-old client took part in a Moderna Covid-19 vaccine clinical trial.

Photo: Paul Hennessy/Zuma Press

Released at Sun, 31 Oct 2021 16:34:00 +0000

https://www.wsj.com/articles/moderna-confirms-fda-delayed-covid-19-vaccine-in-adolescents-to-review-myocarditis-risk-11635698082?mod=pls_whats_news_us_business_f.

Previous articleMcAuliffe Hires Marc Elias, the Left’s Most Toxic Legal General
Next articleYour Libra Tarot Horoscope for the Month Ahead